Variant report
Variant | esv3323550 |
---|---|
Chromosome Location | chr10:18408346-18412744 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181724677 | chr10:18408640-18408641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532997981 | chr10:18408647-18408648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544802716 | chr10:18408662-18408663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185353556 | chr10:18408664-18408665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530507908 | chr10:18408689-18408690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs60638967 | chr10:18408757-18408758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549030594 | chr10:18408761-18408762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116145277 | chr10:18408763-18408764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528046736 | chr10:18408814-18408815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574065798 | chr10:18408832-18408833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571961224 | chr10:18408864-18408865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147379726 | chr10:18408865-18408866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372437816 | chr10:18408866-18408867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10828253 | chr10:18408883-18408884 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs375699334 | chr10:18408932-18408933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190133437 | chr10:18408939-18408940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11012743 | chr10:18408949-18408950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs536367658 | chr10:18409033-18409034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554999082 | chr10:18409047-18409048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573164054 | chr10:18409101-18409102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10828254 | chr10:18409137-18409138 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs117142117 | chr10:18409141-18409142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181754650 | chr10:18409144-18409145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186535434 | chr10:18409158-18409159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35600537 | chr10:18409159-18409160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563355049 | chr10:18409200-18409201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201688976 | chr10:18409840-18409841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80255112 | chr10:18409845-18409846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375635157 | chr10:18409897-18409898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557014947 | chr10:18409945-18409946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113600505 | chr10:18409954-18409955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536086071 | chr10:18409963-18409964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11814616 | chr10:18409966-18409967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573045497 | chr10:18410015-18410016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116756920 | chr10:18410028-18410029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112886479 | chr10:18410038-18410039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185133186 | chr10:18410071-18410072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140275190 | chr10:18410075-18410076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145262711 | chr10:18410081-18410082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563066536 | chr10:18410092-18410093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111573024 | chr10:18410114-18410115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530402578 | chr10:18410120-18410121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs137880590 | chr10:18410121-18410122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571923236 | chr10:18410141-18410142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191114859 | chr10:18410156-18410157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7478172 | chr10:18410168-18410169 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs552263669 | chr10:18410178-18410179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34909585 | chr10:18410189-18410190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35900015 | chr10:18410191-18410192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs537900245 | chr10:18410204-18410205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 16616336 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:18408600-18409200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr10:18409800-18412600 | Weak transcription | Fetal Heart | heart |
3 | chr10:18410400-18410600 | Bivalent Enhancer | Fetal Kidney | kidney |
4 | chr10:18410600-18410800 | Flanking Bivalent TSS/Enh | Fetal Kidney | kidney |
5 | chr10:18412600-18413200 | Enhancers | Fetal Heart | heart |